Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Total 13F shares
-
242,885,517
-
Share change
-
+1,257,757
-
Total reported value
-
$57,767,796,924
-
Put/Call ratio
-
88%
-
Price per share
-
$237.95
-
Number of holders
-
832
-
Value change
-
+$325,722,381
-
Number of buys
-
437
-
Number of sells
-
346
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q1 2020
As of 31 Mar 2020,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
832 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
242,885,517 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Capital World Investors, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, Capital International Investors, and ALLIANCEBERNSTEIN L.P..
This page lists
837
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.